Zen Technologies Board Approves Unaudited Results, Ashok Atluri Re-appointed
Zen Technologies’ Board of Directors approved the standalone and consolidated unaudited financial results for Q3 2026 and re-appointed…
GAIL Reports Q3 FY26 Results, Announces Interim Dividend of ₹5.00
GAIL (India) Limited announced its Q3 FY26 results, reporting a profit of ₹1,602.57 crore. The board has declared an interim dividend of ₹5.00…
IDFC FIRST Bank Reports Q3 FY26 Results, Net Profit Up to ₹50.25 Crore
IDFC FIRST Bank announced its financial results for Q3 FY26, reporting a net profit of ₹50.25 crore, compared to ₹33.94 crore in Q3 FY25. The…
Akums Drugs & Pharmaceuticals Board Meeting to Approve Quarterly Results
Akums Drugs & Pharmaceuticals will hold a board meeting on February 13, 2026, to consider and approve the unaudited standalone and…
Bharat Dynamics Board Declares Interim Dividend of ₹4.50 Per Share
The Board of Directors of Bharat Dynamics Limited has declared an interim dividend of ₹4.50 per share, for the financial year 2025-26. This…
Birla Corporation Board Approves Q3 Results, Extends Key Personnel Terms
Birla Corporation’s Board approved the unaudited financial results for Q3 FY26, with standalone revenue at ₹1,197.94 Crores and a profit…
Clean Science and Technology Declares Interim Dividend; Q3 Results Announced
Clean Science and Technology has announced its Q3 results and declared an interim dividend of ₹2/- per equity share. The company’s…
Vinati Organics Reports Q3 Results, Dividend & Policy Revisions
Vinati Organics Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company’s…
AstraZeneca Board Meeting Scheduled to Approve Unaudited Financial Results
AstraZeneca Pharma India Ltd. has announced a meeting of its Board of Directors on February 11, 2026, to consider and approve the unaudited…
Advanced Enzymes Approves Wind Power Collaboration, Q3 2026 Results
Advanced Enzymes has approved a collaboration for a Group Captive Wind Power Plant, investing up to 26% equity stake in a Special Purpose…